リウマチ性心疾患とのHLAクラスII関連は,臨床的に均質な患者の間でより明らかで一貫しています
Y Guédez1, A Kotby, M El-Demellawy
1Veterans Affairs Medical Center, The University of Tennessee, Memphis, TN, USA.
Circulation
|June 3, 1999
まとめ
ヒューマン白血球抗原 (HLA) クラスIIアレルは,リウマチ性心疾患 (RHD) のリスクと保護と関連しています. これらの関連性は,ミトラル弁疾患のような特定の臨床症状を有する患者でより明確である.
科学分野:
- 免疫遺伝学 免疫遺伝学
- レウマトロジーの病理学
- 分子生物学は分子生物学である.
背景:
- 以前の研究では,リウマチ性心疾患 (RHD) との対立するHLAクラスII関連が報告されました.
- 不一致は,信頼性の低い血清学的タイプ化や定義されていない患者の臨床分類から生じる可能性があります.
- この研究では,定義された臨床結果を持つRHD患者における分子HLA関連性を調査しています.
研究 の 目的:
- ヒト白血球抗原 (HLA) クラスIIとリウマチ性心疾患 (RHD) の間の分子関連性を調査する.
- 異なる臨床分類を有するRHD患者のHLAクラスIIアレルおよびハプロタイプ分布を分析する.
- RHDに対するリスクまたは保護を与える特定のHLAアレルおよびハプロタイプを特定する.
主な方法:
- 88人のRHD患者と59人の対照群におけるHLAクラスIIアレルおよびハプロタイプの遺伝子型決定.
- RHD患者の分類は,ミトラ弁疾患 (MVD) と多弁性病変 (MVL) に分類する.
- 患者グループと対照群の間のアレル/ハプロタイプ頻度を比較するための統計分析.
主要な成果:
- RHD患者では,DRB1*0701およびDQA1*0201アレルおよびDRB1*0701-DQA1*0201ハプロタイプの大幅な増加が観察されました.
- DQA1*0103アレル頻度は低下し,DQB1*0603は患者さんには存在せず,保護効果を示唆した.
- HLA関連は,MVDサブグループでは,MVLサブグループと比較して,より強く,より一貫していました.
結論:
- 特定のHLAクラスIIアレルとハプロタイプは,RHDにおけるリスクと保護に関連しています.
- DRB1*0701-DQA1*0201ハプロタイプは,RHDリスクと関連しています.
- 均質な臨床グループ (例えば,MVD) での分析は,HLA-RHD関連性の明確性を高めます.
関連する概念動画
Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...


